Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Change in Account Payables (2018 - 2026)

10x Genomics' Change in Account Payables history spans 8 years, with the latest figure at -$5.4 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 59.56% to -$5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.1 million, a 36.61% increase, with the full-year FY2025 number at -$2.1 million, up 36.61% from a year prior.
  • Change in Account Payables hit -$5.4 million in Q4 2025 for 10x Genomics, down from -$196000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for TXG hit a ceiling of $10.9 million in Q1 2021 and a floor of -$13.4 million in Q4 2024.
  • Historically, Change in Account Payables has averaged $272250.0 across 5 years, with a median of -$210000.0 in 2022.
  • Biggest five-year swings in Change in Account Payables: surged 1766.92% in 2021 and later crashed 1331.25% in 2023.
  • Tracing TXG's Change in Account Payables over 5 years: stood at -$1.1 million in 2021, then surged by 79.77% to -$224000.0 in 2022, then crashed by 1331.25% to -$3.2 million in 2023, then tumbled by 317.9% to -$13.4 million in 2024, then skyrocketed by 59.56% to -$5.4 million in 2025.
  • Business Quant data shows Change in Account Payables for TXG at -$5.4 million in Q4 2025, -$196000.0 in Q3 2025, and $6.0 million in Q2 2025.